Clinical Trials Directory

Trials / Unknown

UnknownNCT04361773

Effect of Photobiomodulation on the Treatment of Soft Tissue Traumatic Injuries

Effect of Photobiomodulation on the Treatment of Soft Tissue Traumatic Injuries: Study Protocol for a Double-Blind, Randomized, Controlled Trial

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
University of Nove de Julho · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Soft tissue injuries are directly related to the energy of the trauma and its repair is the main factor for bone healing and the recovery of the function of the affected limb. Photobiomodulation (PBM) is indicated as an adjuvant treatment to accelerate wound healing, however, there is still a lack of evidence regarding its effect on traumatic soft tissue injuries. This project aims to evaluate the effects of the application of PBM in the resolution of complex soft tissue injuries of traumatic origin associated with tibial fractures. 84 adult individuals, aged between 18 and 60 years, hospitalized with tibial fractures awaiting resolution of soft tissue injuries will be included to undergo definitive surgery. The subjects will be randomized in two groups: PBM (treated with a device with 144 LED emitting diodes at wavelengths of 420, 660 and 850nm, 3J per point for 10 minutes) and Sham (simulation of the LED application, with a device with characteristics identical to that of the PBM group, for the same period of time). Subjects will be treated daily until release for surgery. The primary outcome will be the assessment of the wound healing process using the BATES-JENSEN scale. Secondary outcomes will be: pain intensity; consumption of analgesic drugs; serum evolution of inflammatory markers C-reactive protein and creatine kinase, measurement of the lesion area, time needed for release for definitive surgery, presence of infection, and the cost-effectiveness of PBM. The evaluations will be carried out before the beginning of the intervention and daily until the participant is considered ready for surgery (which will be considered the end of the experimental period). Data will be analyzed statistically considering a significance level of 5%.

Conditions

Interventions

TypeNameDescription
RADIATIONPhotobiomodulationTreatment with a device with 144 light emitting diodes (LEDs) at wavelengths of 420, 660 and 850nm, 3J per point for 10 minutes.
OTHERSham PhotobiomodulationSimulation of the LED application, with a device with external characteristics identical to that of the PBM group, for the same period of time.

Timeline

Start date
2020-05-30
Primary completion
2021-05-30
Completion
2021-12-30
First posted
2020-04-24
Last updated
2020-04-24

Source: ClinicalTrials.gov record NCT04361773. Inclusion in this directory is not an endorsement.